Praxis Precision Medicines, Inc. Profile Avatar - Palmy Investing

Praxis Precision Medicines, Inc.

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA rec…

Biotechnology
US, Boston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Praxis Precision Medicines, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Praxis Precision Medicines, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Praxis Precision Medicines, Inc..

End of PRAX's Analysis
CIK: 1689548 CUSIP: 74006W108 ISIN: US74006W2070 LEI: - UEI: -
Secondary Listings
PRAX has no secondary listings inside our databases.